Menu
← Oncology Approval Tracker
FDA DECISION ·
Jylamvo
methotrexate oral solution · Shorla Oncology
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Pediatric patients with acute lymphoblastic leukemia, as part of a combination chemotherapy maintenance regimen.
LAMPGEN ANALYSIS
Why it matters
The oral methotrexate solution gained an ALL maintenance indication for children.
What research teams should watch
Use clear weekly-dose instructions and verify solution concentration and volume to prevent dosing errors.
PRIMARY RECORDS